UEG Week: Novel procedure combined with semaglutide may eliminate insulin dependency in type 2 diabetes
October 14, 2024 | 05:01
Groundbreaking research presented today at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that could significantly reduce or even eliminate the need for insulin therapy.
Optimising diabetes treatment with digital enablers
September 22, 2022 | 15:50
OneClinic Co., Ltd. and the Cardiff Diabetes Centre on September 20 signed a strategic cooperation agreement to optimise the diabetes treatment model.
New approach of diabetes management to protect kidney at early stage
March 14, 2020 | 14:11
The Ho Chi Minh City Diabetes and Endocrinology Association and AstraZeneca hosted a webinar on the benefits of SGLT2i class in type 2 diabetes management.
Novo Nordisk opens new office in Ho Chi Minh City. 1
November 08, 2012 | 10:00
Denmark-based healthcare company Novo Nordisk decided to open a new office in Ho Chi Minh City, a step to further expand its business in Vietnam.
Mobile Version